[Treatment of hepatitis B].
Marcellin
P
P
Service d'hépatologie, Inserm U-481 et Centre de recherche Claude Bernard sur les hépatites virales, Hôpital Beaujon, 93000 Clichy, France.
Castelnau
C
C
Boyer
N
N
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use*; D063065:Organophosphonates; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D063065:Organophosphonates; D019259:Lamivudine; C053001:adefovir; D000225:Adenine
Traitement de l'hépatite B.